Lawsuit: Arca Biopharma investor cries foul on merger proposal – BizWest bizwest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizwest.com Daily Mail and Mail on Sunday newspapers.
Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) issued its quarterly earnings data on Monday. The company reported ($1.20) EPS for the quarter, missing the consensus estimate of ($0.90) by ($0.30), Zacks reports. Spyre Therapeutics Stock Performance Shares of SYRE opened at $37.38 on Thursday. Spyre Therapeutics has a fifty-two week low of $2.66 and a […]
Spyre Therapeutics (NASDAQ:SYRE) Issues Quarterly Earnings Results kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Spyre Therapeutics (NASDAQ:SYRE) Releases Quarterly Earnings Results, Misses Estimates By $0.30 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Spyre Therapeutics Appoints Accomplished Biopharma Leader Dr. Sandra Milligan to its Board of Directors prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.